Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe

Comparison of the Accuracy and Precision of NovoLog® Mix 70/30 FlexPen® to Vial and Syringe in Patients With Type 2 Diabetes Mellitus

This trial is conducted in the United States of America (USA). The aim of this trial is to compare desired (target) with actual target amounts of insulin dispensed using NovoLog® Mix 70/30 FlexPen® and vial and syringe in subjects with type 2 diabetes mellitus. No insulin is administered in this trial - insulin is dispensed into an empty vial.

Inclusion Criteria:

• Type 2 diabetes
• Insulin naive
• No previous experience administering injections

Exclusion Criteria:

• Any condition that, in the Investigator and/or Sponsor's opinion, could interfere with the results of this trial